|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 124.40 PLN | +1.47% |
|
+1.30% | -8.66% |
| 27/05 | Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip' | RE |
| 15/05 | Scope Fluidics Q1 net loss at 13.5 million zlotys | RE |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | 198.2 | +59.32% | 1 | ||||
| 49.1 | +3.74% | 10 | ||||||
| 20.14 | +14.45% | 7 | ||||||
| - | - | 48.3 | +41.19% | 1 | ||||
| 8.8 | +115.69% | 10 | ||||||
| 25.8 | +12.32% | 5 | ||||||
| 39,500 | +40.82% | 2 | ||||||
| 5.7 | +14.46% | 5 | ||||||
| 8.333 | +48.54% | 3 | ||||||
| Average | 4,429.38 | +38.95% | 5 | ||||||
| Weighted average by Cap. | 2,542.52 | +31.35% | 7 |
- Stock Market
- Stocks
- SCP Stock
- Sector Scope Fluidics S.A.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
